BridgeMD
New treatment option for ICU Acquired Weakness (ICUAW)
Official title Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge
ClinicalTrials.gov ID: NCT07489092
What this study is testing
- What it's testing
- This study aims to evaluate the feasibility, usability, and clinical effectiveness of a digital rehabilitation platform in adult patients discharged from the intensive care unit (ICU). Adult patients aged 19 years or older who stayed in the ICU for more than 48 hours and are capable of using a smartphone will be enrolled from two tertiary hospitals in South Korea.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age 19 years or older.
- Admission to the intensive care unit (ICU) for more than 48 hours.
- Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
- Discharge from the ICU at the time of enrollment.
- Ownership of a smartphone and ability to operate a digital rehabilitation platform.
You likely can't join if
- Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
- Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
- Unstable medical conditions requiring ongoing intensive medical treatment.
- Inability to use a smartphone or digital platform independently.
- Refusal to participate or withdrawal of informed consent.
See the full eligibility criteria
- Age 19 years or older.
- Admission to the intensive care unit (ICU) for more than 48 hours.
- Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
- Discharge from the ICU at the time of enrollment.
- Ownership of a smartphone and ability to operate a digital rehabilitation platform.
- Ability to understand the study procedures and provide voluntary written informed consent.
- Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
- Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
- Unstable medical conditions requiring ongoing intensive medical treatment.
- Inability to use a smartphone or digital platform independently.
- Refusal to participate or withdrawal of informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.